208 related articles for article (PubMed ID: 18550032)
1. Loss of glial glutamate and aspartate transporter (excitatory amino acid transporter 1) causes locomotor hyperactivity and exaggerated responses to psychotomimetics: rescue by haloperidol and metabotropic glutamate 2/3 agonist.
Karlsson RM; Tanaka K; Heilig M; Holmes A
Biol Psychiatry; 2008 Nov; 64(9):810-4. PubMed ID: 18550032
[TBL] [Abstract][Full Text] [Related]
2. Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia.
Karlsson RM; Tanaka K; Saksida LM; Bussey TJ; Heilig M; Holmes A
Neuropsychopharmacology; 2009 May; 34(6):1578-89. PubMed ID: 19078949
[TBL] [Abstract][Full Text] [Related]
3. Reversal of novelty-induced hyperlocomotion and hippocampal c-Fos expression in GluA1 knockout male mice by the mGluR2/3 agonist LY354740.
Procaccini C; Maksimovic M; Aitta-Aho T; Korpi ER; Linden AM
Neuroscience; 2013 Oct; 250():189-200. PubMed ID: 23867766
[TBL] [Abstract][Full Text] [Related]
4. The group II metabotropic glutamate receptor agonist LY354740 and the D2 receptor antagonist haloperidol reduce locomotor hyperactivity but fail to rescue spatial working memory in GluA1 knockout mice.
Boerner T; Bygrave AM; Chen J; Fernando A; Jackson S; Barkus C; Sprengel R; Seeburg PH; Harrison PJ; Gilmour G; Bannerman DM; Sanderson DJ
Eur J Neurosci; 2017 Apr; 45(7):912-921. PubMed ID: 28186680
[TBL] [Abstract][Full Text] [Related]
5. The mGluR
Sokolenko E; Hudson MR; Nithianantharajah J; Jones NC
J Psychopharmacol; 2019 Dec; 33(12):1588-1599. PubMed ID: 31580222
[TBL] [Abstract][Full Text] [Related]
6. A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity.
Galici R; Echemendia NG; Rodriguez AL; Conn PJ
J Pharmacol Exp Ther; 2005 Dec; 315(3):1181-7. PubMed ID: 16123306
[TBL] [Abstract][Full Text] [Related]
7. The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity.
Woolley ML; Pemberton DJ; Bate S; Corti C; Jones DN
Psychopharmacology (Berl); 2008 Feb; 196(3):431-40. PubMed ID: 18057917
[TBL] [Abstract][Full Text] [Related]
8. Involvement of glutamatergic and GABAergic transmission in MK-801-increased gamma band oscillation power in rat cortical electroencephalograms.
Hiyoshi T; Kambe D; Karasawa J; Chaki S
Neuroscience; 2014 Nov; 280():262-74. PubMed ID: 25220900
[TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.
Halberstadt AL; van der Zee JVF; Chatha M; Geyer MA; Powell SB
Psychopharmacology (Berl); 2019 Feb; 236(2):821-830. PubMed ID: 30448990
[TBL] [Abstract][Full Text] [Related]
10. Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychotics.
Bradford AM; Savage KM; Jones DN; Kalinichev M
Psychopharmacology (Berl); 2010 Oct; 212(2):155-70. PubMed ID: 20676613
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of the metabotropic glutamate (mGlu) 2 receptor attenuates the MK-801-induced increase in the immobility time in the forced swimming test in rats.
Kawaura K; Karasawa J; Hikichi H
Pharmacol Rep; 2016 Feb; 68(1):80-4. PubMed ID: 26721357
[TBL] [Abstract][Full Text] [Related]
12. Functional roles of the glial glutamate transporter (GLAST) in emotional and cognitive abnormalities of mice after repeated phencyclidine administration.
Uchida M; Hida H; Mori K; Yoshimi A; Kitagaki S; Yamada K; Hiraoka Y; Aida T; Tanaka K; Ozaki N; Noda Y
Eur Neuropsychopharmacol; 2019 Aug; 29(8):914-924. PubMed ID: 31303267
[TBL] [Abstract][Full Text] [Related]
13. mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia.
Engel M; Snikeris P; Matosin N; Newell KA; Huang XF; Frank E
Psychopharmacology (Berl); 2016 Apr; 233(8):1349-59. PubMed ID: 26861891
[TBL] [Abstract][Full Text] [Related]
14. The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade.
Leriche L; Schwartz JC; Sokoloff P
Neuropharmacology; 2003 Aug; 45(2):174-81. PubMed ID: 12842123
[TBL] [Abstract][Full Text] [Related]
15. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
Cartmell J; Monn JA; Schoepp DD
J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
[TBL] [Abstract][Full Text] [Related]
16. The glutamatergic compounds sarcosine and N-acetylcysteine ameliorate prepulse inhibition deficits in metabotropic glutamate 5 receptor knockout mice.
Chen HH; Stoker A; Markou A
Psychopharmacology (Berl); 2010 May; 209(4):343-50. PubMed ID: 20217053
[TBL] [Abstract][Full Text] [Related]
17. Activation of group II metabotropic glutamate receptors induces long-term depression of excitatory synaptic transmission in the substantia nigra pars reticulata.
Johnson KA; Niswender CM; Conn PJ; Xiang Z
Neurosci Lett; 2011 Oct; 504(2):102-106. PubMed ID: 21945652
[TBL] [Abstract][Full Text] [Related]
18. Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge.
Lorrain DS; Schaffhauser H; Campbell UC; Baccei CS; Correa LD; Rowe B; Rodriguez DE; Anderson JJ; Varney MA; Pinkerton AB; Vernier JM; Bristow LJ
Neuropsychopharmacology; 2003 Sep; 28(9):1622-32. PubMed ID: 12825094
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of metabotropic glutamate (mGlu) 2 receptor and blockade of mGlu1 receptor improve social memory impairment elicited by MK-801 in rats.
Hikichi H; Kaku A; Karasawa J; Chaki S
J Pharmacol Sci; 2013; 122(1):10-6. PubMed ID: 23603933
[TBL] [Abstract][Full Text] [Related]
20. Phencyclidine and dizocilpine induced behaviors reduced by N-acetylaspartylglutamate peptidase inhibition via metabotropic glutamate receptors.
Olszewski RT; Wegorzewska MM; Monteiro AC; Krolikowski KA; Zhou J; Kozikowski AP; Long K; Mastropaolo J; Deutsch SI; Neale JH
Biol Psychiatry; 2008 Jan; 63(1):86-91. PubMed ID: 17597589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
